Thus, elevation of IL1-B in the systemic circulation (induced by sleep disruption, cancer, chemotherapy, etc.)effect sleep neurocircuitry via vagal input and likely enter the brain parenchyma via aforementioned mechanisms (i.e., BBB-mediated transport and/or passive diffusion at circumventricular organs) resulting in aberrant neuronal activity. Here, IL1B is linked to cancer.